• CRG
  • CRG
  • CRG

Centre for Genomic Regulation (CRG)

CRG

The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, created in December 2000. The mission of the CRG is to discover and advance knowledge for the benefit of society, public health and economic prosperity. The CRG believes that the medicine of the future depends on the groundbreaking science of today. This requires an interdisciplinary scientific team focused on understanding the complexity of life from the genome to the cell to a whole organism and its interaction with the environment, offering an integrated view of genetic diseases. CRG is an international institute, with 65% of the PI and 78% of the PhD students being non-nationals.

Excellence and recognition awards

CRG has a successful external funding record:

  • 20 European Research Council (ERC) grants
  • 8 active H2020 projects, 5 of which coordinated by CRG PIs, (17 H2020 projects in total)
  • 29 active FP7 projects, 7 of which coordinated by CRG PIs (74 FP7 projects in total)
Ranking positioning
  • 2015 – 6th  worldwide position in the health sector, according to Q1 – Ratio of Publications indicator in the 2015 Scimago Institutions Ranking report.
Director of the center
Luis Serrano

Luis Serrano

Luis Serrano is the director of the CRG and senior group leader of the Systems Biology Program. He completed his PhD on Cell Biology at the Centro de Biología Molecular Severo Ochoa (CBM) in Madrid (Spain). He is an EMBO and RACEFyN member and has received the Marie Curie Excellence Award. He has also received support through the prestigious European Research Comission (ERC) Advanced Grant and has participated as a principal investigator in numerous research projects financed both by the ERC (through the 6th and 7th Framework Programmes) and the Ministry of Science and Innovation of Spain. He is Professor at the Catalan Institution for Research and Advanced Studies (ICREA) and has directed 14 PhD theses.

Renowned researcher
Fyodor Kondrashov

Fyodor Kondrashov

Fyodor Kondrashov studied genetic evolution at the graduate level, getting his master’s degree in population biology from the University of California, Davis (USA), and his PhD in evolutionary biology from the University of California, San Diego (USA), where he studied under the supervision of the biologist Doris Bachtrog. In Bachtrog’s lab, Kondrashov analyzed how gene duplications affect evolution and the analysis of genome evolution as a whole. In 2008, he went directly from grad school to heading his own lab at the Center for Genomic Regulation (CRG) in Barcelona. He is also recipient of several international awards and, in parallel to his research, he leads several outreach and education projects. Since 2012, he is the main organizer and scientific director if the School of Molecular and Theoretical Biology (SMTB).

The project

Neurodegenerative disorders are common diseases that affect our society. They are characterized by the loss of neurons within the brain and/or spinal cord, which results in a progressive deterioration of the function of the central and peripheral nervous system. Nowadays, no cure exists for these diseases. Neurodegeneration can affect individuals of all ages, but becomes increasingly frequent with age. With the ageing of the general population, the prevalence of these disorders is expected to rise dramatically in the next few decades. Some researchers at the CRG aim to decipher the mechanisms underlying these diseases with the hope of finding a cure someday. Help us to better understand neurodegeneration!